DRUG RECALL

Bipolar Med by Unichem Laboratories Recalled

October 6, 2016

The US Food and Drug Administration (FDA) reported the recall of lamotrigine tablets, USP, 150 mg.

The medication (NDC 29300-113-05) was packaged in 500-count bottles.

What prompted the Class III recall? The tablets had the incorrect identification imprinted on them, according to the FDA’s Enforcement Report.

__________________________________________________________________________________________________________________________________________________________________________

RELATED CONTENT
Massive Recall of Blood Thinners, Antibiotic
Sandoz Recalls Hypotension Med, Vasoconstrictor

_______________________________________________________________________________________________________________________________________________________________________________________________________________________

The impacted lot is #GLEH 16003, with an expiration date of March 31, 2018.

The products were manufactured by Unichem Laboratories in India and distributed nationwide.

In August, Impax Laboratories recalled one lot of lamotrigine orally disintegrating tablets.

 

--Stephanie Vaccaro

 

Reference:

US Food and Drug Administration. FDA Enforcement Report – Week of October 5, 2016. www.fda.gov. Accessed October 5, 2016.